S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AGRX Agile Therapeutics Inc

0.6022

0.00 (0.00%)

After Hours

Last Updated: 10:00:00

Delayed by 15 minutes

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
agrx-20221231xars.pdf

Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Agile Therapeutics Charts.

Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Agile Therapeutics Charts.

Agile Therapeutics Inc News

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.

Agile Therapeutics Announces Delisting from Nasdaq
Tuesday 26 March 2024 (1 month ago) • GlobeNewswire Inc.

Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
Thursday 21 March 2024 (2 months ago) • GlobeNewswire Inc.

Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
Wednesday 20 March 2024 (2 months ago) • GlobeNewswire Inc.

Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)

Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
Friday 23 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
Friday 16 February 2024 (3 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)

More Agile Therapeutics Inc News Articles

Newcrest Mining

Woodside Petroleum

Verizon Communications

JP Morgan Chase

National Australia Bank

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions